Physician profile
Hesham Malik
NPI 1194942011
$46,063.18
in general payments reported to CMS, 2019-2025
12 companies · $394 in 2025
The $394 reported for 2025 was more than what 77% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $16K · 2021: $6,091 · 2022: $4,715 · 2023: $356 · 2024: $635 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $20,274.11 | 2019-2022 | |
| Cook Incorporated | $14,400.00 | 2019-2020 | |
| Boston Scientific Corporation | $6,428.53 | 2019-2022 | |
| Biocompatibles, INC. | $1,752.23 | 2019 | |
| Cook Medical LLC | $1,181.68 | 2019-2020 | |
| Asahi Intecc USA, INC. | $668.26 | 2024-2025 | Peripheral Vascular, Asahi Interventional Radiology Wires, Asahi Peripheral Vascular Wires |
| Terumo Medical Corporation | $619.93 | 2022-2025 | Azur Cx Detachable, Angio-Seal, Hydropearl |
| Trisalus Life Sciences, INC. | $566.87 | 2020-2023 | Trinav Infusion System |
| Guerbet LLC | $63.36 | 2023 | |
| Siemens Medical Solutions USA, INC. | $55.40 | 2023-2024 | Embozene |
| Balt USA, LLC | $37.65 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $15.16 | 2023 | Precisetumor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hesham Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.